TheraRadar
← Back
Data updated: Mar 29, 2026

ALMATICA

Infectious DiseaseCardiovascular
Big Pharma

ALMATICA is a major pharmaceutical company focused on Infectious Disease, Cardiovascular. Key products include LOREEV XR.

1970
Since
10
Drugs
-
Trials
64
Approved (2yr)

Key Drugs

GRALISE
gabapentin
1 indications · 2011
LOREEV XR
lorazepam
CNS
GABA A receptor 1 indications · 2021
ESCITALOPRAM
escitalopram oxalate
· 2025

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2025-11-20
Manufacturing (CMC)
ESCITALOPRAM 2025-08-29
Type 3 - New Dosage Form
SERTRALINE HYDROCHLORIDE 2025-08-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 67%
2 drugs
Cardiovascular 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular
B BRAUN specialty
Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease